环磷酰胺和异环磷酰胺的对映体。 - Suppr

Suppr

超能文献

Enantiomers of cyclophosphamide and iphosphamide.

作者信息

Farmer P B

机构信息

MRC Toxicology Unit, MRC Laboratories, Carshalton, Surrey, U.K.

出版信息

Biochem Pharmacol. 1988 Jan 1;37(1):145-8. doi: 10.1016/0006-2952(88)90767-8.

DOI:10.1016/0006-2952(88)90767-8

PMID:3337735

Abstract

摘要

相似文献

Enantiomers of cyclophosphamide and iphosphamide.环磷酰胺和异环磷酰胺的对映体。

Biochem Pharmacol. 1988 Jan 1;37(1):145-8. doi: 10.1016/0006-2952(88)90767-8.

Cyclophosphamide versus ifosfamide: to use ifosfamide or not to use, that is the three-dimensional question.环磷酰胺与异环磷酰胺：用或不用异环磷酰胺，这是个三维问题。

Curr Pharm Des. 1999 Aug;5(8):665-72.

Genetically engineered V79 Chinese hamster cells metabolically activate the cytostatic drugs cyclophosphamide and ifosfamide.基因工程改造的V79中国仓鼠细胞可代谢激活细胞生长抑制剂环磷酰胺和异环磷酰胺。

Environ Health Perspect. 1990 Aug;88:63-5. doi: 10.1289/ehp.908863.

Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites.异环磷酰胺及其代谢产物的临床药代动力学和药效学

Clin Pharmacokinet. 2001 Jan;40(1):41-62. doi: 10.2165/00003088-200140010-00004.

An overview of cyclophosphamide and ifosfamide pharmacology.环磷酰胺与异环磷酰胺药理学概述。

Pharmacotherapy. 1997 Sep-Oct;17(5 Pt 2):146S-154S.

Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. I. Antitumour effect of cyclophosphamide and ifosfamide enantiomers.环磷酰胺和异环磷酰胺的 /+/R 及 /-/S 对映体生物活性的比较研究。I. 环磷酰胺和异环磷酰胺对映体的抗肿瘤作用。

Arch Immunol Ther Exp (Warsz). 1986;34(3):275-84.

Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. II. Antiproliferative activity of cyclophosphamide and ifosfamide enantiomers.环磷酰胺和异环磷酰胺的 /+/R 及 /-/S 对映体的生物活性比较研究。II. 环磷酰胺和异环磷酰胺对映体的抗增殖活性。

Arch Immunol Ther Exp (Warsz). 1986;34(3):285-91.

Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines.原代人肝细胞培养物中环磷酰胺和异环磷酰胺的活化增强：对细胞色素P-450诱导剂的反应以及氧氮磷啶的自身诱导作用。

Cancer Res. 1997 May 15;57(10):1946-54.

Pharmacokinetics of ifosfamide and some metabolites in children.

Anticancer Res. 1998 May-Jun;18(3B):1941-9.

Metabolism and pharmacokinetics of oxazaphosphorines.恶唑磷类化合物的代谢与药代动力学

Clin Pharmacokinet. 2000 Apr;38(4):291-304. doi: 10.2165/00003088-200038040-00001.

引用本文的文献

Stereoselective pharmacokinetics of ifosfamide in male and female rats.异环磷酰胺在雄性和雌性大鼠体内的立体选择性药代动力学

AAPS PharmSci. 2000;2(2):E17. doi: 10.1208/ps020217.

New insights into the pharmacokinetics and metabolism of (R,S)-ifosfamide in cancer patients using a population pharmacokinetic-metabolism model.

Pharm Res. 2000 Jun;17(6):645-52. doi: 10.1023/a:1007561727948.

Ifosfamide enantiomers: pharmacokinetics in children.异环磷酰胺对映体：儿童药代动力学

Cancer Chemother Pharmacol. 1994;34(5):447-9. doi: 10.1007/BF00685573.

Urinary excretion of the enantiomers of ifosfamide and its inactive metabolites in children.

Cancer Chemother Pharmacol. 1991;28(6):455-60. doi: 10.1007/BF00685822.

Metabolism and pharmacokinetics of oral and intravenous ifosfamide.口服和静脉注射异环磷酰胺的代谢及药代动力学

J Cancer Res Clin Oncol. 1991;117 Suppl 4(Suppl 4):S148-53. doi: 10.1007/BF01613221.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验